Industry Research Reports

Home > Reports > Pharma & Healthcare > Global Conjunctivitis Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2025-2031

Global Conjunctivitis Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2025-2031

Industry: Pharma & Healthcare

Published Date: 2025-03-28

Pages: 132 Pages

Report ld: 4674879

Request Sample

Customized Report

Description
Table of Contents
Table of Figures
Related Reports
PDF Download

Description
Table of Contents
Table of Figures
Related Reports
PDF Download

Conjunctivitis Market Size(US$)

CAGR 2025-2031

1.6%

Market Size,2031

USD 4,099

Million

Market Snapshot

Market Size in 2025 (Value)

US$ 3,727 million

Market Forecast in 2031(Value)

US$ 4,099 million

CAGR

1.6%

Years Considered

2020-2031

Base Year

2025

Forecast Period

2025-2031

Source: Secondary research, interviews with experts, and QYResearch analysis

In 2024, the global market size of Conjunctivitis was estimated to be worth US$ 3674 million and is forecast to reach approximately US$ 4099 million by 2031 with a CAGR of 1.6% during the forecast period 2025-2031.

Conjunctivitis, or inflammation of the conjunctiva, is a general term that refers to a diverse group of diseases/disorders that affect the conjunctiva primarily. Most varieties of conjunctivitis are self-limited, but some progress and may cause serious ocular and extraocular complications.

Conjunctivitis is more commonly referred to as pink eye. The whites of the eyes appear pink or red when the conjunctiva (the transparent membrane which lines part of the eyeball) becomes inflamed or infected.

The technical barriers of conjunctivitis industry are existed apparently. The key technology and higher level products are in the hand of the global leading enterprise like Novartis, Santen Pharmaceutical, Bausch + Lomb, Allergan, Sun Pharmaceutical, Akorn and Sinqi, etc.

biaoTi REPORT SCOPE

This report aims to provide a comprehensive presentation of the global market for Conjunctivitis, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Conjunctivitis.

The Conjunctivitis market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Conjunctivitis market comprehensively. Regional market sizes, concerning products by Type, by End User, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Conjunctivitis manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by End User, and regions.

By Company

Novartis (CH)

Santen Pharmaceutical (JP)

Bausch & Lomb (US)

Allergan (US)

Sun Pharmaceutical (ID)

Akorn (US)

Freda (CN)

Sinqi (CN)

Univision (CN)

Segment by Type

Antibiotic

Pills

Ointment

Segment by End User

Newborns

Children

Adults

By Region

North America

United States

Canada

Asia-Pacific

China

Japan

South Korea

India

Southeast Asia

Australia

Rest of Asia-Pacific

Europe

Germany

France

U.K.

Italy

Russia

Nordic Countries

Rest of Europe

Latin America

Mexico

Brazil

Rest of Latin America

Middle East & Africa

Turkey

Saudi Arabia

UAE

Rest of MEA

biaoTi CHAPTER OUTLINE

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type and by End User, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Sales (consumption), revenue of Conjunctivitis in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.

Chapter 3: Detailed analysis of Conjunctivitis manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Conjunctivitis sales, revenue, price, gross margin, sales by region, by Type, by End User, and recent development, etc.

Chapter 5: Provides the analysis of various market segments by Type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by End User, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: North America by Type, by End User and by country, sales, and revenue for each segment.

Chapter 8: APAC by Type, by End User and by country, sales, and revenue for each segment.

Chapter 9: Europe by Type, by End User and by country, sales, and revenue for each segment.

Chapter 10: Latin America by Type, by End User and by country, sales, and revenue for each segment.

Chapter 11: Middle East and Africa by Type, by End User and by country, sales, and revenue for each segment.

Chapter 12: Analysis of industrial chain, sales channel, key raw materials, distributors, and customers.

Chapter 13: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 14: Research Findings and Conclusion.

biaoTi QYRESEARCH'S STRENGTHS

Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:

Market entry risks/opportunities by region

We identify regional market threats and growth prospects to guide your overseas layout.

Product mix optimization based on local practices

We adjust product portfolios in line with local consumption habits.

Competitor tactics in fragmented vs. consolidated markets

We unpack rivals’ operation strategies for scattered and highly concentrated industries.

Full Research Coverage

We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.

19 Years Industry Expertise

We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.

24/7 Fast Report Delivery

Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.

Localized Strategic Analysis

We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.

Market entry risks/opportunities by region

All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.

Market entry risks/opportunities by region

We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.

TABLE OF CONTENTS

1 Study Coverage

1.1 Conjunctivitis Product Introduction

1.2 Market by Type

1.2.1 Global Conjunctivitis Market Size Growth Rate by Type (2020 VS 2024 VS 2031)

1.2.2 Antibiotic

1.2.3 Pills

1.2.4 Ointment

1.3 Market by End User

1.3.1 Global Conjunctivitis Market Size Growth Rate by End User (2020 VS 2024 VS 2031)

1.3.2 Newborns

1.3.3 Children

1.3.4 Adults

1.4 Study Objectives

1.5 Years Considered

2 Executive Summary

2.1 Global Conjunctivitis Market Size Estimates and Forecasts

2.1.1 Global Conjunctivitis Revenue 2020-2031

2.1.2 Global Conjunctivitis Sales 2020-2031

2.2 Conjunctivitis Market Size by Region: 2024 Versus 2031

2.3 Conjunctivitis Sales by Region (2020-2031)

2.3.1 Global Conjunctivitis Sales by Region: 2020-2025

2.3.2 Global Conjunctivitis Sales Forecast by Region (2026-2031)

2.3.3 Global Conjunctivitis Sales Market Share by Region (2020-2031)

2.4 Conjunctivitis Market Estimates and Projections by Region (2026-2031)

2.4.1 Global Conjunctivitis Revenue by Region: 2020-2025

2.4.2 Global Conjunctivitis Revenue Forecast by Region (2026-2031)

2.4.3 Global Conjunctivitis Revenue Market Share by Region (2020-2031)

3 Market Segments

3.1 Breakdown Data by Type

3.1.1 Global Conjunctivitis Sales by Type (2020-2031)

3.1.1.1 Global Conjunctivitis Sales Volume by Type (2020-2031)

3.1.1.2 Global Conjunctivitis Sales Market Share by Type (2020-2031)

3.1.2 Global Conjunctivitis Revenue by Type (2020-2031)

3.1.2.1 Global Conjunctivitis Revenue by Type (2020-2031)

3.1.2.2 Global Conjunctivitis Revenue Market Share by Type (2020-2031)

3.1.3 Conjunctivitis Average Selling Price (ASP) by Type (2020-2031)

3.2 Breakdown Data by End User

3.2.1 Global Conjunctivitis Sales by End User (2020-2031)

3.2.1.1 Global Conjunctivitis Sales Volume by End User (2020-2031)

3.2.1.2 Global Conjunctivitis Sales Market Share by End User (2020-2031)

3.2.2 Global Conjunctivitis Revenue by End User (2020-2031)

3.2.2.1 Global Conjunctivitis Revenue by End User (2020-2031)

3.2.2.2 Global Conjunctivitis Revenue Market Share by End User (2020-2031)

3.2.3 Conjunctivitis Average Selling Price (ASP) by End User (2020-2031)

3.3 by Type and by End User Crossing Analysis

3.3.1 Antibiotic of Conjunctivitis Revenue Market Share by End User

3.3.2 Pills of Conjunctivitis Revenue Market Share by End User

3.3.3 Ointment of Conjunctivitis Revenue Market Share by End User

4 Global Conjunctivitis by Manufacturers

4.1 Global Top Conjunctivitis Manufacturers by Sales (2020-2025)

4.1.1 Global Conjunctivitis Sales by Manufacturer (2020-2025)

4.1.2 Global Conjunctivitis Sales Market Share by Manufacturer (2020-2025)

4.2 Global Top Conjunctivitis Manufacturers by Revenue (2020-2025)

4.2.1 Global Conjunctivitis Revenue by Manufacturer (2020-2025)

4.2.2 Global Conjunctivitis Revenue Share by Manufacturer (2020-2025)

4.3 Global Conjunctivitis Price by Manufacturer (2020-2025)

4.4 Competitive Landscape

4.4.1 Key Conjunctivitis Manufacturers Covered: Ranking by Revenue

4.4.2 Global Conjunctivitis Market Concentration Ratio (CR5 and HHI) & (2020-2025)

4.4.3 Global Conjunctivitis Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

4.5 Global Conjunctivitis Manufacturing Base Distribution, Product Type

4.5.1 Conjunctivitis Manufacturers Manufacturing Base Distribution, Headquarters

4.5.2 Date of International Manufacturers Enter into Conjunctivitis Market

4.5.3 Manufacturers Conjunctivitis Product Type and Application

4.5.4 Antibiotic Market Sales of Conjunctivitis by Manufacturer

4.5.5 Pills Market Sales of Conjunctivitis by Manufacturer

4.5.6 Ointment Market Sales of Conjunctivitis by Manufacturer

4.6 Manufacturers Mergers & Acquisitions, Expansion Plans

5 Company Profiles

5.1 Novartis (CH)

5.1.1 Novartis (CH) Company Information

5.1.2 Novartis (CH) Description, Business Overview

5.1.3 Novartis (CH) Conjunctivitis Products Offered

5.1.4 Novartis (CH) Conjunctivitis Sales, Revenue and Gross Margin (2020-2025)

5.1.5 Novartis (CH) Conjunctivitis Sales by Product in 2024

5.1.6 Novartis (CH) Conjunctivitis Sales by End User in 2024

5.1.7 Novartis (CH) Conjunctivitis Sales by Geographic Area in 2024

5.1.8 Novartis (CH) Recent Developments

5.2 Santen Pharmaceutical (JP)

5.2.1 Santen Pharmaceutical (JP) Company Information

5.2.2 Santen Pharmaceutical (JP) Description, Business Overview

5.2.3 Santen Pharmaceutical (JP) Conjunctivitis Products Offered

5.2.4 Santen Pharmaceutical (JP) Conjunctivitis Sales, Revenue and Gross Margin (2020-2025)

5.2.5 Santen Pharmaceutical (JP) Conjunctivitis Sales by Product in 2024

5.2.6 Santen Pharmaceutical (JP) Conjunctivitis Sales by End User in 2024

5.2.7 Santen Pharmaceutical (JP) Conjunctivitis Sales by Geographic Area in 2024

5.2.8 Santen Pharmaceutical (JP) Recent Developments

5.3 Bausch & Lomb (US)

5.3.1 Bausch & Lomb (US) Company Information

5.3.2 Bausch & Lomb (US) Description, Business Overview

5.3.3 Bausch & Lomb (US) Conjunctivitis Products Offered

5.3.4 Bausch & Lomb (US) Conjunctivitis Sales, Revenue and Gross Margin (2020-2025)

5.3.5 Bausch & Lomb (US) Conjunctivitis Sales by Product in 2024

5.3.6 Bausch & Lomb (US) Conjunctivitis Sales by End User in 2024

5.3.7 Bausch & Lomb (US) Conjunctivitis Sales by Geographic Area in 2024

5.3.8 Bausch & Lomb (US) Recent Developments

5.4 Allergan (US)

5.4.1 Allergan (US) Company Information

5.4.2 Allergan (US) Description, Business Overview

5.4.3 Allergan (US) Conjunctivitis Products Offered

5.4.4 Allergan (US) Conjunctivitis Sales, Revenue and Gross Margin (2020-2025)

5.4.5 Allergan (US) Conjunctivitis Sales by Product in 2024

5.4.6 Allergan (US) Conjunctivitis Sales by End User in 2024

5.4.7 Allergan (US) Conjunctivitis Sales by Geographic Area in 2024

5.4.8 Allergan (US) Recent Developments

5.5 Sun Pharmaceutical (ID)

5.5.1 Sun Pharmaceutical (ID) Company Information

5.5.2 Sun Pharmaceutical (ID) Description, Business Overview

5.5.3 Sun Pharmaceutical (ID) Conjunctivitis Products Offered

5.5.4 Sun Pharmaceutical (ID) Conjunctivitis Sales, Revenue and Gross Margin (2020-2025)

5.5.5 Sun Pharmaceutical (ID) Conjunctivitis Sales by Product in 2024

5.5.6 Sun Pharmaceutical (ID) Conjunctivitis Sales by End User in 2024

5.5.7 Sun Pharmaceutical (ID) Conjunctivitis Sales by Geographic Area in 2024

5.5.8 Sun Pharmaceutical (ID) Recent Developments

5.6 Akorn (US)

5.6.1 Akorn (US) Company Information

5.6.2 Akorn (US) Description, Business Overview

5.6.3 Akorn (US) Conjunctivitis Products Offered

5.6.4 Akorn (US) Conjunctivitis Sales, Revenue and Gross Margin (2020-2025)

5.6.5 Akorn (US) Conjunctivitis Sales by Product in 2024

5.6.6 Akorn (US) Conjunctivitis Sales by End User in 2024

5.6.7 Akorn (US) Conjunctivitis Sales by Geographic Area in 2024

5.6.8 Akorn (US) Recent Developments

5.7 Freda (CN)

5.7.1 Freda (CN) Company Information

5.7.2 Freda (CN) Description, Business Overview

5.7.3 Freda (CN) Conjunctivitis Products Offered

5.7.4 Freda (CN) Conjunctivitis Sales, Revenue and Gross Margin (2020-2025)

5.7.5 Freda (CN) Conjunctivitis Sales by Product in 2024

5.7.6 Freda (CN) Conjunctivitis Sales by End User in 2024

5.7.7 Freda (CN) Conjunctivitis Sales by Geographic Area in 2024

5.7.8 Freda (CN) Recent Developments

5.8 Sinqi (CN)

5.8.1 Sinqi (CN) Company Information

5.8.2 Sinqi (CN) Description, Business Overview

5.8.3 Sinqi (CN) Conjunctivitis Products Offered

5.8.4 Sinqi (CN) Conjunctivitis Sales, Revenue and Gross Margin (2020-2025)

5.8.5 Sinqi (CN) Conjunctivitis Sales by Product in 2024

5.8.6 Sinqi (CN) Conjunctivitis Sales by End User in 2024

5.8.7 Sinqi (CN) Conjunctivitis Sales by Geographic Area in 2024

5.8.8 Sinqi (CN) Recent Developments

5.9 Univision (CN)

5.9.1 Univision (CN) Company Information

5.9.2 Univision (CN) Description, Business Overview

5.9.3 Univision (CN) Conjunctivitis Products Offered

5.9.4 Univision (CN) Conjunctivitis Sales, Revenue and Gross Margin (2020-2025)

5.9.5 Univision (CN) Conjunctivitis Sales by Product in 2024

5.9.6 Univision (CN) Conjunctivitis Sales by End User in 2024

5.9.7 Univision (CN) Conjunctivitis Sales by Geographic Area in 2024

5.9.8 Univision (CN) Recent Developments

6 North America

6.1 North America Conjunctivitis Market Size YoY Growth 2020-2031

6.2 North America Conjunctivitis Market Facts & Figures by Country

6.2.1 North America Conjunctivitis Sales by Country (2020-2031)

6.2.2 North America Conjunctivitis Revenue by Country (2020-2031)

6.3 North America Conjunctivitis Sales by Type (2020-2025)

6.4 North America Conjunctivitis Sales by End User (2020-2025)

7 Asia-Pacific

7.1 Asia-Pacific Conjunctivitis Market Size YoY Growth 2020-2031

7.2 Asia-Pacific Conjunctivitis Market Facts & Figures by Region

7.2.1 Asia-Pacific Conjunctivitis Sales by Region (2020-2031)

7.2.2 Asia-Pacific Conjunctivitis Revenue by Region (2020-2031)

7.3 Asia-Pacific Conjunctivitis Sales by Type (2020-2025)

7.4 Asia-Pacific Conjunctivitis Sales by End User (2020-2025)

8 Europe

8.1 Europe Conjunctivitis Market Size YoY Growth 2020-2031

8.2 Europe Conjunctivitis Market Facts & Figures by Country

8.2.1 Europe Conjunctivitis Sales by Country (2020-2031)

8.2.2 Europe Conjunctivitis Revenue by Country (2020-2031)

8.3 Europe Conjunctivitis Sales by Type (2020-2025)

8.4 Europe Conjunctivitis Sales by End User (2020-2025)

9 Latin America

9.1 Latin America Conjunctivitis Market Size YoY Growth 2020-2031

9.2 Latin America Conjunctivitis Market Facts & Figures by Country

9.2.1 Latin America Conjunctivitis Sales by Country (2020-2031)

9.2.2 Latin America Conjunctivitis Revenue by Country (2020-2031)

9.3 Latin America Conjunctivitis Sales by Type (2020-2025)

9.4 Latin America Conjunctivitis Sales by End User (2020-2025)

10 Middle East and Africa

10.1 Latin America Conjunctivitis Market Size YoY Growth 2020-2031

10.2 Middle East and Africa Conjunctivitis Market Facts & Figures by Country

10.2.1 Middle East and Africa Conjunctivitis Sales by Country (2020-2031)

10.2.2 Middle East and Africa Conjunctivitis Revenue by Country (2020-2031)

10.3 Middle East and Africa Conjunctivitis Sales by Type (2020-2025)

10.4 Middle East and Africa Conjunctivitis Sales by End User (2020-2025)

11 Supply Chain and Sales Channel analysis

11.1 Conjunctivitis Supply Chain Analysis

11.2 Conjunctivitis Key Raw Materials and Upstream Suppliers

11.3 Conjunctivitis Clients Analysis

11.4 Conjunctivitis Sales Channel and Sales Model Analysis

11.4.1 Conjunctivitis Distribution Channel Analysis: Indirect Sales VS Direct Sales

11.4.2 Conjunctivitis Distribution Channel Analysis: Online Sales VS Offline Sales

11.4.3 Conjunctivitis Distributors

12 Conjunctivitis Market Dynamics

12.1 Conjunctivitis Industry Trends

12.2 Conjunctivitis Market Drivers

12.3 Conjunctivitis Market Challenges

12.4 Conjunctivitis Market Restraints

13 Research Findings and Conclusion

14 Appendix

14.1 Research Methodology

14.1.1 Methodology/Research Approach

14.1.1.1 Research Programs/Design

14.1.1.2 Market Size Estimation

14.1.1.3 Market Breakdown and Data Triangulation

14.1.2 Data Source

14.1.2.1 Secondary Sources

14.1.2.2 Primary Sources

14.2 Author Details

14.3 Disclaimer

TABLE OF FIGURES

List of Tables

Table 1. Global Conjunctivitis Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031

Table 2. Global Conjunctivitis Market Size Growth by End User (US$ Million): 2020 VS 2024 VS 2031

Table 3. Global Conjunctivitis Market Size by Region (US$ Million): 2024 VS 2031

Table 4. Global Conjunctivitis Sales by Region (2020-2025) & (K Units)

Table 5. Global Conjunctivitis Sales Forecast by Region (2026-2031) & (K Units)

Table 6. Global Conjunctivitis Revenue by Region (2020-2025) & (US$ Million)

Table 7. Global Conjunctivitis Revenue Forecast by Region (2026-2031) & (US$ Million)

Table 8. Global Conjunctivitis Sales Volume by Type (2020-2025) & (K Units)

Table 9. Global Conjunctivitis Sales Volume by Type (2026-2031) & (K Units)

Table 10. Global Conjunctivitis Revenue by Type (2020-2025) & (US$ Million)

Table 11. Global Conjunctivitis Revenue Forecast by Type (2026-2031) & (US$ Million)

Table 12. Global Conjunctivitis Sales Volume by End User (2020-2025) & (K Units)

Table 13. Global Conjunctivitis Sales Volume by End User (2026-2031) & (K Units)

Table 14. Global Conjunctivitis Revenue by End User (2020-2025) & (US$ Million)

Table 15. Global Conjunctivitis Revenue by End User (2026-2031) & (US$ Million)

Table 16. Global Conjunctivitis Sales by Manufacturer (2020-2025) & (K Units)

Table 17. Global Conjunctivitis Sales Share by Manufacturer (2020-2025)

Table 18. Conjunctivitis Revenue by Manufacturer (2020-2025) & (US$ Million)

Table 19. Conjunctivitis Revenue Share by Manufacturer (2020-2025)

Table 20. Key Manufacturers Conjunctivitis Price (2020-2025) & (USD/Unit)

Table 21. Ranking of Global Top Conjunctivitis Manufacturers by Revenue (US$ Million) in 2024

Table 22. Global Conjunctivitis Manufacturers Market Concentration Ratio (CR5 and HHI) & (2020-2025)

Table 23. Global Conjunctivitis by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Conjunctivitis as of 2024)

Table 24. Conjunctivitis Manufacturers Manufacturing Base Distribution and Headquarters

Table 25. Date of International Manufacturers Enter into Conjunctivitis Market

Table 26. Manufacturers Conjunctivitis Product Type and Application

Table 27. Manufacturers Mergers & Acquisitions, Expansion Plans

Table 28. Novartis (CH) Company Information

Table 29. Novartis (CH) Description and Business Overview

Table 30. Novartis (CH) Conjunctivitis Product

Table 31. Novartis (CH) Conjunctivitis Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)

Table 32. Novartis (CH) Sales Proportion of Conjunctivitis by Product in 2024

Table 33. Novartis (CH) Sales Proportion of Conjunctivitis by End User in 2024

Table 34. Novartis (CH) Sales Proportion of Conjunctivitis by Geographic Area in 2024

Table 35. Novartis (CH) Recent Developments

Table 36. Santen Pharmaceutical (JP) Company Information

Table 37. Santen Pharmaceutical (JP) Description and Business Overview

Table 38. Santen Pharmaceutical (JP) Conjunctivitis Product

Table 39. Santen Pharmaceutical (JP) Conjunctivitis Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)

Table 40. Santen Pharmaceutical (JP) Sales Proportion of Conjunctivitis by Product in 2024

Table 41. Santen Pharmaceutical (JP) Sales Proportion of Conjunctivitis by End User in 2024

Table 42. Santen Pharmaceutical (JP) Sales Proportion of Conjunctivitis by Geographic Area in 2024

Table 43. Santen Pharmaceutical (JP) Recent Developments

Table 44. Bausch & Lomb (US) Company Information

Table 45. Bausch & Lomb (US) Description and Business Overview

Table 46. Bausch & Lomb (US) Conjunctivitis Product

Table 47. Bausch & Lomb (US) Conjunctivitis Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)

Table 48. Bausch & Lomb (US) Sales Proportion of Conjunctivitis by Product in 2024

Table 49. Bausch & Lomb (US) Sales Proportion of Conjunctivitis by End User in 2024

Table 50. Bausch & Lomb (US) Sales Proportion of Conjunctivitis by Geographic Area in 2024

Table 51. Bausch & Lomb (US) Recent Developments

Table 52. Allergan (US) Company Information

Table 53. Allergan (US) Description and Business Overview

Table 54. Allergan (US) Conjunctivitis Product

Table 55. Allergan (US) Conjunctivitis Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)

Table 56. Allergan (US) Sales Proportion of Conjunctivitis by Product in 2024

Table 57. Allergan (US) Sales Proportion of Conjunctivitis by End User in 2024

Table 58. Allergan (US) Sales Proportion of Conjunctivitis by Geographic Area in 2024

Table 59. Allergan (US) Recent Developments

Table 60. Sun Pharmaceutical (ID) Company Information

Table 61. Sun Pharmaceutical (ID) Description and Business Overview

Table 62. Sun Pharmaceutical (ID) Conjunctivitis Product

Table 63. Sun Pharmaceutical (ID) Conjunctivitis Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)

Table 64. Sun Pharmaceutical (ID) Sales Proportion of Conjunctivitis by Product in 2024

Table 65. Sun Pharmaceutical (ID) Sales Proportion of Conjunctivitis by End User in 2024

Table 66. Sun Pharmaceutical (ID) Sales Proportion of Conjunctivitis by Geographic Area in 2024

Table 67. Sun Pharmaceutical (ID) Recent Developments

Table 68. Akorn (US) Company Information

Table 69. Akorn (US) Description and Business Overview

Table 70. Akorn (US) Conjunctivitis Product

Table 71. Akorn (US) Conjunctivitis Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)

Table 72. Akorn (US) Sales Proportion of Conjunctivitis by Product in 2024

Table 73. Akorn (US) Sales Proportion of Conjunctivitis by End User in 2024

Table 74. Akorn (US) Sales Proportion of Conjunctivitis by Geographic Area in 2024

Table 75. Akorn (US) Recent Developments

Table 76. Freda (CN) Company Information

Table 77. Freda (CN) Description and Business Overview

Table 78. Freda (CN) Conjunctivitis Product

Table 79. Freda (CN) Conjunctivitis Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)

Table 80. Freda (CN) Sales Proportion of Conjunctivitis by Product in 2024

Table 81. Freda (CN) Sales Proportion of Conjunctivitis by End User in 2024

Table 82. Freda (CN) Sales Proportion of Conjunctivitis by Geographic Area in 2024

Table 83. Freda (CN) Recent Developments

Table 84. Sinqi (CN) Company Information

Table 85. Sinqi (CN) Description and Business Overview

Table 86. Sinqi (CN) Conjunctivitis Product

Table 87. Sinqi (CN) Conjunctivitis Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)

Table 88. Sinqi (CN) Sales Proportion of Conjunctivitis by Product in 2024

Table 89. Sinqi (CN) Sales Proportion of Conjunctivitis by End User in 2024

Table 90. Sinqi (CN) Sales Proportion of Conjunctivitis by Geographic Area in 2024

Table 91. Sinqi (CN) Recent Developments

Table 92. Univision (CN) Company Information

Table 93. Univision (CN) Description and Business Overview

Table 94. Univision (CN) Conjunctivitis Product

Table 95. Univision (CN) Conjunctivitis Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)

Table 96. Univision (CN) Sales Proportion of Conjunctivitis by Product in 2024

Table 97. Univision (CN) Sales Proportion of Conjunctivitis by End User in 2024

Table 98. Univision (CN) Sales Proportion of Conjunctivitis by Geographic Area in 2024

Table 99. Univision (CN) Recent Developments

Table 100. North America Conjunctivitis Sales by Country (2020-2025) & (K Units)

Table 101. North America Conjunctivitis Sales by Country (2026-2031) & (K Units)

Table 102. North America Conjunctivitis Revenue by Country (2020-2025) & (US$ Million)

Table 103. North America Conjunctivitis Revenue by Country (2026-2031) & (US$ Million)

Table 104. North America Conjunctivitis Sales by Type (2020-2025) & (K Units)

Table 105. North America Conjunctivitis Sales by End User (2020-2025) & (K Units)

Table 106. Asia-Pacific Conjunctivitis Sales by Region (2020-2025) & (K Units)

Table 107. Asia-Pacific Conjunctivitis Sales by Region (2026-2031) & (K Units)

Table 108. Asia-Pacific Conjunctivitis Revenue by Region (2020-2025) & (US$ Million)

Table 109. Asia-Pacific Conjunctivitis Revenue by Region (2026-2031) & (US$ Million)

Table 110. Asia-Pacific Conjunctivitis Sales by Type (2020-2025) & (K Units)

Table 111. Asia-Pacific Conjunctivitis Sales by End User (2020-2025) & (K Units)

Table 112. Europe Conjunctivitis Sales by Country (2020-2025) & (K Units)

Table 113. Europe Conjunctivitis Sales by Country (2026-2031) & (K Units)

Table 114. Europe Conjunctivitis Revenue by Country (2020-2025) & (US$ Million)

Table 115. Europe Conjunctivitis Revenue by Country (2026-2031) & (US$ Million)

Table 116. Europe Conjunctivitis Sales by Type (2020-2025) & (K Units)

Table 117. Europe Conjunctivitis Sales by End User (2020-2025) & (K Units)

Table 118. Latin America Conjunctivitis Sales by Country (2020-2025) & (K Units)

Table 119. Latin America Conjunctivitis Sales by Country (2026-2031) & (K Units)

Table 120. Latin America Conjunctivitis Revenue by Country (2020-2025) & (US$ Million)

Table 121. Latin America Conjunctivitis Revenue by Country (2026-2031) & (US$ Million)

Table 122. Latin America Conjunctivitis Sales by Type (2020-2025) & (K Units)

Table 123. Latin America Conjunctivitis Sales by End User (2020-2025) & (K Units)

Table 124. Middle East and Africa Conjunctivitis Sales by Country (2020-2025) & (K Units)

Table 125. Middle East and Africa Conjunctivitis Sales by Country (2026-2031) & (K Units)

Table 126. Middle East and Africa Conjunctivitis Revenue by Country (2020-2025) & (US$ Million)

Table 127. Middle East and Africa Conjunctivitis Revenue by Country (2026-2031) & (US$ Million)

Table 128. Middle East and Africa Conjunctivitis Sales by Type (2020-2025) & (K Units)

Table 129. Middle East and Africa Conjunctivitis Sales by End User (2020-2025) & (K Units)

Table 130. Conjunctivitis Key Raw Materials, Industry Status and Trend

Table 131. Conjunctivitis Key Raw Materials and Upstream Suppliers

Table 132. Conjunctivitis Clients Status and Trend

Table 133. Conjunctivitis Typical Clients

Table 134. Conjunctivitis Distributors

Table 135. Conjunctivitis Market Trends

Table 136. Conjunctivitis Market Drivers

Table 137. Conjunctivitis Market Challenges

Table 138. Conjunctivitis Market Restraints

Table 139. Research Programs/Design for This Report

Table 140. Key Data Information from Secondary Sources

Table 141. Key Data Information from Primary Sources

Table 142. QYR Business Unit and Senior & Team Lead Analysts

List of Figures

Figure 1. Conjunctivitis Product Picture

Figure 2. Global Conjunctivitis Market Size by Type (US$ Million): 2020 VS 2024 VS 2031

Figure 3. Global Conjunctivitis Sales Market Share by Type in 2024 & 2031

Figure 4. Antibiotic Product Picture

Figure 5. Pills Product Picture

Figure 6. Ointment Product Picture

Figure 7. Global Conjunctivitis Market Size by End User (US$ Million): 2020 VS 2024 VS 2031

Figure 8. Global Conjunctivitis Sales Market Share by End User in 2024 & 2031

Figure 9. Newborns

Figure 10. Children

Figure 11. Adults

Figure 12. Conjunctivitis Report Years Considered

Figure 13. Global Conjunctivitis Revenue, (US$ Million), 2020 VS 2024 VS 2031

Figure 14. Global Conjunctivitis Market Size 2020-2031 (US$ Million)

Figure 15. Global Conjunctivitis Sales 2020-2031 (K Units)

Figure 16. Global Conjunctivitis Sales Market Share Forecast by Region (2020-2031)

Figure 17. Global Conjunctivitis Revenue Market Share by Region (2020-2031)

Figure 18. Global Conjunctivitis Sales Market Share Forecast by Type (2020-2031)

Figure 19. Global Conjunctivitis Revenue Market Share Forecast by Type (2020-2031)

Figure 20. Conjunctivitis Average Selling Price (ASP) by Type (2020-2025) & (USD/Unit)

Figure 21. Global Conjunctivitis Sales Market Share Forecast by End User (2020-2031)

Figure 22. Global Conjunctivitis Revenue Market Share Forecast by End User (2020-2031)

Figure 23. Conjunctivitis Average Selling Price (ASP) by End User (2020-2025) & (USD/Unit)

Figure 24. Antibiotic of Conjunctivitis Revenue Market Share by End User, 2024 VS 2031

Figure 25. Pills of Conjunctivitis Revenue Market Share by End User, 2024 VS 2031

Figure 26. Ointment of Conjunctivitis Revenue Market Share by End User, 2024 VS 2031

Figure 27. Global Conjunctivitis Sales Share by Manufacturer in 2024

Figure 28. Conjunctivitis Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024

Figure 29. Antibiotic Market Sales Proportion by Manufacturer in 2024

Figure 30. Pills Market Sales Proportion by Manufacturer in 2024

Figure 31. Ointment Market Sales Proportion by Manufacturer in 2024

Figure 32. North America Conjunctivitis Revenue 2020-2031 (US$ Million)

Figure 33. North America Conjunctivitis Sales Market Share by Type (2020-2025)

Figure 34. North America Conjunctivitis Sales Market Share by End User (2020-2025)

Figure 35. Asia-Pacific Conjunctivitis Revenue 2020-2031 (US$ Million)

Figure 36. Asia-Pacific Conjunctivitis Sales Market Share by Region (2020-2031)

Figure 37. Asia-Pacific Conjunctivitis Revenue Market Share by Region (2020-2031)

Figure 38. Asia-Pacific Conjunctivitis Sales Market Share by Type (2020-2025)

Figure 39. Asia-Pacific Conjunctivitis Sales Market Share by End User (2020-2025)

Figure 40. Europe Conjunctivitis Revenue Growth Rate 2020-2031 (US$ Million)

Figure 41. Europe Conjunctivitis Sales Market Share by Country (2020-2031)

Figure 42. Europe Conjunctivitis Revenue Market Share by Country (2020-2031)

Figure 43. Europe Conjunctivitis Sales Market Share by Type (2020-2025)

Figure 44. Europe Conjunctivitis Sales Market Share by End User (2020-2025)

Figure 45. Latin America Conjunctivitis Revenue Growth Rate 2020-2031 (US$ Million)

Figure 46. Latin America Conjunctivitis Sales Market Share by Country (2020-2031)

Figure 47. Latin America Conjunctivitis Revenue Market Share by Country (2020-2025)

Figure 48. Latin America Conjunctivitis Sales Market Share by Type (2020-2025)

Figure 49. Latin America Conjunctivitis Sales Market Share by End User (2020-2025)

Figure 50. Middle East and Africa Conjunctivitis Revenue Growth Rate 2020-2031 (US$ Million)

Figure 51. Middle East and Africa Conjunctivitis Sales Market Share by Country (2020-2031)

Figure 52. Middle East and Africa Conjunctivitis Revenue Market Share by Country (2020-2031)

Figure 53. Middle East and Africa Conjunctivitis Sales Market Share by Type (2020-2025)

Figure 54. Middle East and Africa Conjunctivitis Sales Market Share by End User (2020-2025)

Figure 55. Conjunctivitis Supply Chain (Upstream and Downstream Market)

Figure 56. Global Production Market Share of Conjunctivitis Raw Materials by Region in 2024

Figure 57. Conjunctivitis Distribution Channels

Figure 58. Global Conjunctivitis Percentage 2020-2031: Indirect Sales VS Direct Sales

Figure 59. Global Conjunctivitis Percentage 2020-2031: Online Sales VS Offline Sales

Figure 60. Bottom-up and Top-down Approaches for This Report

Figure 61. Data Triangulation

Figure 62. Key Executives Interviewed

KEY QUESTIONS ADDRESSED BY THE REPORT

What is the annual compound growth rate of the global Conjunctivitis market size from 2025 to 2031? zhanKai

The annual compound growth rate of the global Conjunctivitis market is 1.6% 2025 to 2031.

What was the global market size of Conjunctivitis in 2025? shouQi

Which region is expected to have the highest market share? shouQi

Which companies rank high in the global Conjunctivitis market? shouQi

What was the global market size of Conjunctivitis in 2031? shouQi

Related Reports

Global Conjunctivitis Sales Market Report, Competitive Analysis and Regional Opportunities 2026-2032
The global Conjunctivitis market size was US$ 3727 million in 2025 and is forecast to reach a readjusted size of US$ 4158 million by 2032 with a CAGR of 1.6% during the forecast period 2026-2032.
Published Date: 2026-01-04
Pages: 79
USD 4250.00
(Single User License)
Global Conjunctivitis Market Research Report 2026
The global Conjunctivitis market was valued at US$ 3727 million in 2025 and is anticipated to reach US$ 4158 million by 2032, at a CAGR of 1.6% from 2026 to 2032.
Published Date: 2026-01-04
Pages: 109
USD 2900.00
(Single User License)
Conjunctivitis- Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for Conjunctivitis was estimated to be worth US$ 3727 million in 2025 and is projected to reach US$ 4158 million, growing at a CAGR of 1.6% from 2026 to 2032.
Published Date: 2026-01-04
Pages: 109
USD 3950.00
(Single User License)
Global Conjunctivitis Market Outlook, In‑Depth Analysis & Forecast to 2031
The global Conjunctivitis market is projected to grow from US$ 3674 million in 2024 to US$ 4099 million by 2031, at a CAGR of 1.6% (2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published Date: 2025-09-11
Pages: 133
USD 4900.00
(Single User License)
Global Conjunctivitis Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global Conjunctivitis market size was US$ 3674 million in 2024 and is forecast to a readjusted size of US$ 4099 million by 2031 with a CAGR of 1.6% during the forecast period 2025-2031.
Published Date: 2025-03-19
Pages: 76
USD 4250.00
(Single User License)
Conjunctivitis- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Conjunctivitis was estimated to be worth US$ 3674 million in 2024 and is forecast to a readjusted size of US$ 4099 million by 2031 with a CAGR of 1.6% during the forecast period 2025-2031.
Published Date: 2025-01-16
Pages: 102
USD 3950.00
(Single User License)
Global Conjunctivitis Market Research Report 2025
The global market for Conjunctivitis was valued at US$ 3674 million in the year 2024 and is projected to reach a revised size of US$ 4099 million by 2031, growing at a CAGR of 1.6% during the forecast period.
Published Date: 2025-01-16
Pages: 82
USD 2900.00
(Single User License)
Global Conjunctivitis Industry Research Report, Growth Trends and Competitive Analysis 2024-2030
Conjunctivitis, or inflammation of the conjunctiva, is a general term that refers to a diverse group of diseases/disorders that affect the conjunctiva primarily. Most varieties of conjunctivitis are self-limited, but some progress and may cause serious ocular and extraocular complications.
Published Date: 2024-04-17
Pages: 141
USD 5600.00
(Single User License)
Global Conjunctivitis Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2024-2030
Conjunctivitis, or inflammation of the conjunctiva, is a general term that refers to a diverse group of diseases/disorders that affect the conjunctiva primarily. Most varieties of conjunctivitis are self-limited, but some progress and may cause serious ocular and extraocular complications.
Published Date: 2024-04-16
Pages: 125
USD 5900.00
(Single User License)
Global Conjunctivitis Market Insights, Forecast to 2030
Conjunctivitis, or inflammation of the conjunctiva, is a general term that refers to a diverse group of diseases/disorders that affect the conjunctiva primarily. Most varieties of conjunctivitis are self-limited, but some progress and may cause serious ocular and extraocular complications.
Published Date: 2024-04-07
Pages: 95
USD 4900.00
(Single User License)

Global Conjunctivitis Sales Market Report, Competitive Analysis and Regional Opportunities 2026-2032
The global Conjunctivitis market size was US$ 3727 million in 2025 and is forecast to reach a readjusted size of US$ 4158 million by 2032 with a CAGR of 1.6% during the forecast period 2026-2032.
Published: 2026-01-04
Pages: 79
USD 4250.00 (Single User License)
Global Conjunctivitis Market Research Report 2026
The global Conjunctivitis market was valued at US$ 3727 million in 2025 and is anticipated to reach US$ 4158 million by 2032, at a CAGR of 1.6% from 2026 to 2032.
Published: 2026-01-04
Pages: 109
USD 2900.00 (Single User License)
Conjunctivitis- Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for Conjunctivitis was estimated to be worth US$ 3727 million in 2025 and is projected to reach US$ 4158 million, growing at a CAGR of 1.6% from 2026 to 2032.
Published: 2026-01-04
Pages: 109
USD 3950.00 (Single User License)
Global Conjunctivitis Market Outlook, In‑Depth Analysis & Forecast to 2031
The global Conjunctivitis market is projected to grow from US$ 3674 million in 2024 to US$ 4099 million by 2031, at a CAGR of 1.6% (2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published: 2025-09-11
Pages: 133
USD 4900.00 (Single User License)
Global Conjunctivitis Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global Conjunctivitis market size was US$ 3674 million in 2024 and is forecast to a readjusted size of US$ 4099 million by 2031 with a CAGR of 1.6% during the forecast period 2025-2031.
Published: 2025-03-19
Pages: 76
USD 4250.00 (Single User License)
Conjunctivitis- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Conjunctivitis was estimated to be worth US$ 3674 million in 2024 and is forecast to a readjusted size of US$ 4099 million by 2031 with a CAGR of 1.6% during the forecast period 2025-2031.
Published: 2025-01-16
Pages: 102
USD 3950.00 (Single User License)
Global Conjunctivitis Market Research Report 2025
The global market for Conjunctivitis was valued at US$ 3674 million in the year 2024 and is projected to reach a revised size of US$ 4099 million by 2031, growing at a CAGR of 1.6% during the forecast period.
Published: 2025-01-16
Pages: 82
USD 2900.00 (Single User License)
Global Conjunctivitis Industry Research Report, Growth Trends and Competitive Analysis 2024-2030
Conjunctivitis, or inflammation of the conjunctiva, is a general term that refers to a diverse group of diseases/disorders that affect the conjunctiva primarily. Most varieties of conjunctivitis are self-limited, but some progress and may cause serious ocular and extraocular complications.
Published: 2024-04-17
Pages: 141
USD 5600.00 (Single User License)
Global Conjunctivitis Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2024-2030
Conjunctivitis, or inflammation of the conjunctiva, is a general term that refers to a diverse group of diseases/disorders that affect the conjunctiva primarily. Most varieties of conjunctivitis are self-limited, but some progress and may cause serious ocular and extraocular complications.
Published: 2024-04-16
Pages: 125
USD 5900.00 (Single User License)
Global Conjunctivitis Market Insights, Forecast to 2030
Conjunctivitis, or inflammation of the conjunctiva, is a general term that refers to a diverse group of diseases/disorders that affect the conjunctiva primarily. Most varieties of conjunctivitis are self-limited, but some progress and may cause serious ocular and extraocular complications.
Published: 2024-04-07
Pages: 95
USD 4900.00 (Single User License)